Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Condition(s):Schizophrenia; Bipolar I DisorderLast Updated:March 20, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Schizophrenia; Bipolar I DisorderLast Updated:March 20, 2024Recruiting
Condition(s):Parkinson Disease PsychosisLast Updated:March 21, 2024Withdrawn
Condition(s):Bipolar DisorderLast Updated:February 8, 2018Completed
Condition(s):Bipolar I DisorderLast Updated:June 29, 2023Active, not recruiting
Condition(s):Safety and Tolerability of IloperidoneLast Updated:June 13, 2016Completed
Condition(s):HealthyLast Updated:July 11, 2022Completed
Condition(s):SchizophreniaLast Updated:June 29, 2023Completed
Condition(s):Post Traumatic Stress DisorderLast Updated:February 11, 2020Terminated
Condition(s):SchizophreniaLast Updated:March 15, 2013Completed
Condition(s):Hepatic ImpairmentLast Updated:March 14, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.